Federal contract award
75N93021F00006
CONTRACT #HHSN272201800001I; SRI INTERNATIONAL; GMP MANUFACTURING OF OXFENDAZOLE CLINICAL TRIAL MATERIAL AND STABILITY STUDY; OA TASK 75N93021F00006; MIS TASK TOIA21C13PIPB-1; BASE AWARD; CAN 8470036; TOTAL $381,002.00
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | 75N93018D00001 |
| Set-aside | Not reported |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $630.6K |
| Current contract value | $630.6K |
| Potential contract value / ceiling | $630.6K |
| Start date | Jul 27, 2021 |
| Current end date | Jun 2, 2025 |
| Potential end date | Jun 2, 2025 |
| Latest award activity | Sep 10, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 8 of 8 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 10, 2026 | P00007 | $-4.2K | TO ADMINISTRATE DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS. |
| Jun 4, 2025 | P00006 | $0 | EOI::ENDING RADICAL AND WASTEFUL GOVERNMENT DEI PROGRAMS AND PREFERENCING (JANUARY 20, 2025)::EOI NOTICE OF TERMINATION FOR CONVENIENCE |
| Nov 14, 2024 | P00005 | $72.3K | NON CLINICAL SERVICES IDIQ |
| Nov 16, 2023 | P00004 | $64.6K | NON CLINICAL SERVICES IDIQ |
| Nov 21, 2022 | P00003 | $110.9K | NON CLINICAL SERVICES IDIQ |
| Nov 18, 2022 | P00002 | $6.0K | NON CLINICAL SERVICES IDIQ |
| Sep 6, 2022 | P00001 | $0 | CONTRACT #HHSN272201800001I; SRI INTERNATIONAL; GMP MANUFACTURING OF OXFENDAZOLE CLINICAL TRIAL MATERIAL AND STABILITY STUDY; OA TASK 75N93021F00006; MIS TASK TOIA21C13PIPB-1; BASE AWARD; CAN 8470036; TOTAL $381,002.00 |
| Jul 27, 2021 | 0 | $381.0K | CONTRACT #HHSN272201800001I; SRI INTERNATIONAL; GMP MANUFACTURING OF OXFENDAZOLE CLINICAL TRIAL MATERIAL AND STABILITY STUDY; OA TASK 75N93021F00006; MIS TASK TOIA21C13PIPB-1; BASE AWARD; CAN 8470036; TOTAL $381,002.00 |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.